| rejected |
507 |
company |
0.611 |
trigram_core |
781 |
name=Knight Foundation | type=firm roles={firm} | sector=- | hq=Miami/US | domains=knightfoundation.org | edges=0 | src_text=- |
1584 |
|
| pending |
3199 |
company |
0.7 |
trigram_core |
1898 |
name=Venture to Future Fund | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
2550 |
|
| pending |
3203 |
company |
0.6 |
trigram_core |
2042 |
name=Aragen Life Sciences | type=company roles={company} | sector=Healthcare | hq=Hyderabad/India | domains=- | edges=0 | src_text=- |
2525 |
|
| pending |
12950 |
company |
0.619 |
trigram_core |
1145 |
name=CA Technologies | type=company roles={company} | sector=Enterprise SaaS | hq=New York/US | domains=ca.com | edges=2 | src_text=- |
5033 |
|
| pending |
12951 |
company |
0.619 |
trigram_core |
1145 |
name=CA Technologies | type=company roles={company} | sector=Enterprise SaaS | hq=New York/US | domains=ca.com | edges=2 | src_text=- |
5284 |
|
| pending |
12972 |
company |
0.692 |
trigram_core |
2535 |
name=Circadian Ventures | type=firm roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
5063 |
|
| pending |
12977 |
company |
0.609 |
trigram_core |
3314 |
name=Rise Therapeutics, LLC | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
5169 |
|
| pending |
12979 |
company |
0.739 |
trigram_core |
3746 |
name=Accelevir Diagnostics, LLC | type=company roles={} | sector=Diagnostics | hq=-/US | domains=- | edges=0 | src_text=- |
5014 |
|
| pending |
12980 |
company |
0.654 |
trigram_core |
4534 |
name=Natsar Pharmaceuticals, Inc. | type=company roles={} | sector=Pharmaceuticals | hq=-/US | domains=- | edges=0 | src_text=- |
5263 |
|
| pending |
12982 |
company |
0.619 |
trigram_core |
4677 |
name=MS Technologies Corporation | type=? roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
5033 |
|
| pending |
12983 |
company |
0.636 |
trigram_core |
4677 |
name=MS Technologies Corporation | type=? roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
5164 |
|
| pending |
12984 |
company |
0.619 |
trigram_core |
4677 |
name=MS Technologies Corporation | type=? roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
5284 |
|
| pending |
12995 |
company |
0.615 |
trigram_core |
4987 |
name=PhaseBio Pharmaceuticals | type=company roles={} | sector=Pharmaceuticals | hq=-/US | domains=- | edges=1 | src_text=- |
5263 |
|
| pending |
12996 |
company |
0.609 |
trigram_core |
5027 |
name=ALung Technologies, Inc. | type=company roles={} | sector=Life Sciences | hq=-/US | domains=- | edges=1 | src_text=- |
5033 |
|
| pending |
17529 |
company |
0.636 |
trigram_core |
4677 |
name=MS Technologies Corporation | type=? roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
5966 |
|
| pending |
17534 |
company |
0.684 |
trigram_core |
4678 |
name=Up Therapeutics, Inc. | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=4 | src_text=- |
6067 |
|
| pending |
17535 |
company |
0.65 |
trigram_core |
4678 |
name=Up Therapeutics, Inc. | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=4 | src_text=- |
6093 |
|
| pending |
17536 |
company |
0.619 |
trigram_core |
4678 |
name=Up Therapeutics, Inc. | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=4 | src_text=- |
6108 |
|
| pending |
17537 |
company |
0.7 |
trigram_core |
4680 |
name=Key Technologies, Inc. | type=? roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
5954 |
|
| pending |
17538 |
company |
0.609 |
trigram_core |
4681 |
name=Othro Therapeutics, Inc. | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6108 |
|
| pending |
17539 |
company |
1.0 |
name_core+trigram_core |
4888 |
name=PromptWrx | type=company roles={} | sector=AI/ML | hq=-/US | domains=- | edges=1 | src_text=- |
5981 |
|
| pending |
17544 |
company |
0.65 |
trigram_core |
4940 |
name=Aer Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6067 |
|
| pending |
17545 |
company |
0.619 |
trigram_core |
4940 |
name=Aer Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6093 |
|
| pending |
17550 |
company |
0.65 |
trigram_core |
4942 |
name=AN2 Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6067 |
|
| pending |
17551 |
company |
0.619 |
trigram_core |
4942 |
name=AN2 Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6093 |
|
| pending |
17553 |
company |
0.609 |
trigram_core |
4998 |
name=Spolia Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6093 |
|
| pending |
17554 |
company |
0.619 |
trigram_core |
5002 |
name=Ten63 Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6067 |
|
| pending |
17555 |
company |
0.65 |
trigram_core |
5004 |
name=Tune Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6067 |
|
| pending |
17556 |
company |
0.619 |
trigram_core |
5004 |
name=Tune Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6093 |
|
| pending |
17559 |
company |
0.6 |
trigram_core |
5164 |
name=Mobile Technologies, Inc. | type=company roles={} | sector=Software | hq=-/US | domains=- | edges=1 | src_text=- |
5966 |
|
| pending |
17560 |
company |
0.667 |
trigram_core |
5169 |
name=Myris Therapeutics | type=company roles={} | sector=Biotechnology | hq=-/US | domains=- | edges=1 | src_text=- |
6067 |
|
| pending |
17561 |
company |
0.636 |
trigram_core |
5232 |
name=Sharp Therapeutics | type=company roles={} | sector=Drug Discovery | hq=-/US | domains=sharptx.com | edges=1 | src_text=- |
6093 |
|
| pending |
17563 |
company |
0.615 |
trigram_core |
5263 |
name=Thar Pharmaceuticals, Inc. | type=company roles={} | sector=Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6109 |
|
| pending |
17569 |
company |
0.609 |
trigram_core |
5715 |
name=Avery Therapeutics | type=company roles={} | sector=Life Sciences | hq=-/US | domains=- | edges=1 | src_text=- |
6108 |
|
| pending |
17570 |
company |
0.609 |
trigram_core |
5792 |
name=Siamab Therapeutics | type=company roles={} | sector=Biotechnology | hq=-/US | domains=- | edges=1 | src_text=- |
6093 |
|
| pending |
17571 |
company |
0.696 |
trigram_core |
5817 |
name=Microchip Technology | type=company roles={company} | sector=- | hq=Chandler/US | domains=- | edges=1 | src_text=- |
6038 |
|
| pending |
17572 |
company |
0.6 |
trigram_core |
5818 |
name=Amkor Technology | type=company roles={company} | sector=- | hq=Tempe/US | domains=- | edges=1 | src_text=- |
5902 |
|
| pending |
17573 |
company |
0.65 |
trigram_core |
6067 |
name=MG Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
6093 |
|
| pending |
17574 |
company |
0.619 |
trigram_core |
6067 |
name=MG Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
6108 |
|
| pending |
21371 |
company |
0.615 |
trigram_core |
235 |
name=Village | type=? roles={company} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
6442 |
|
| pending |
21415 |
company |
1.0 |
name_core+trigram_core |
1169 |
name=JumpStart Inc | type=firm roles={firm} | sector=- | hq=Cleveland/US | domains=jumpstartinc.org | edges=0 | src_text=- |
6480 |
|
| pending |
21417 |
company |
0.731 |
trigram_core |
1181 |
name=Florida A&M University | type=university roles={university} | sector=HBCU 1890 land-grant research university — agriculture (College... |
6397 |
|
| pending |
21418 |
company |
0.632 |
trigram_core |
1216 |
name=Lewis & Clark College | type=university roles={university} | sector=- | hq=Portland/US | domains=lclark.edu | edges=2 | src_text=- |
6405 |
|
| pending |
21420 |
company |
0.786 |
trigram_core |
1417 |
name=University of South Florida | type=university roles={company} | sector=- | hq=Tampa/US | domains=usf.edu | edges=0 | src_text=- |
6397 |
|
| pending |
21430 |
company |
1.0 |
name_core+trigram_core |
1676 |
name=Ascend | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
6412 |
|
| pending |
21433 |
company |
1.0 |
name_core+trigram_core |
1783 |
name=Valley Capital Partners | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=2 | src_text=- |
6456 |
|
| pending |
21438 |
company |
1.0 |
name_core+trigram_core |
1910 |
name=Rebel Ventures | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
6418 |
|
| pending |
21445 |
company |
0.7 |
trigram_core |
2168 |
name=Ascend Asia | type=? roles={company} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
6412 |
|
| pending |
21446 |
company |
0.636 |
trigram_core |
2294 |
name=Startup Capital Ventures | type=firm roles={investor/firm} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
6425 |
|
| pending |
21456 |
company |
0.619 |
trigram_core |
2296 |
name=Ona Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=Ona Therapeuti... |
6498 |
|
| pending |
21469 |
company |
0.632 |
trigram_core |
3651 |
name=Lo Biosciences, Inc. | type=company roles={} | sector=- | hq=-/US | domains=- | edges=0 | src_text=- |
6493 |
|
| pending |
21490 |
company |
0.65 |
trigram_core |
4678 |
name=Up Therapeutics, Inc. | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=4 | src_text=- |
6498 |
|
| pending |
21501 |
company |
0.619 |
trigram_core |
4940 |
name=Aer Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6498 |
|
| pending |
21508 |
company |
0.619 |
trigram_core |
4942 |
name=AN2 Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6498 |
|
| pending |
21511 |
company |
0.682 |
trigram_core |
4998 |
name=Spolia Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6498 |
|
| merged |
21386 |
company |
0.75 |
trigram_core |
708 |
name=Bread and Butter Ventures | type=firm roles={firm} | sector=- | hq=Minneapolis/US | domains=breadandbutterventures.com | edges=0 | s... |
6424 |
|
| merged |
723 |
individual |
0.625 |
structured |
58 |
name=Bob Ackerman | current_co=DataTribe | edges=founded->DataTribe |
632 |
|
| rejected |
715 |
individual |
0.75 |
structured |
121 |
name=Dave Kirkpatrick | current_co=SJF Ventures | edges=founded->SJF Ventures |
752 |
|
| merged |
727 |
individual |
0.895 |
structured |
674 |
name=William B. Register | current_co=- | edges=- |
883 |
|
| merged |
724 |
individual |
0.867 |
structured |
547 |
name=Chad Hoilman | current_co=Ignitio | edges=colleague->?; employed_at->Ignitio |
937 |
|
| merged |
717 |
individual |
0.75 |
structured |
268 |
name=Joshua Kushner | current_co=Thrive Capital | edges=employed_at->Thrive Capital; founded->Thrive Capital |
908 |
|
| merged |
722 |
individual |
0.737 |
structured |
520 |
name=Matthew Strottman | current_co=In-Q-Tel | edges=colleague->?; employed_at->In-Q-Tel |
861 |
|
| merged |
718 |
individual |
0.722 |
structured |
552 |
name=Lisabeth Poulos | current_co=In-Q-Tel | edges=employed_at->In-Q-Tel |
829 |
|
| merged |
725 |
individual |
0.615 |
structured |
533 |
name=Daniel Gwak | current_co=In-Q-Tel | edges=employed_at->In-Q-Tel |
669 |
|
| merged |
726 |
individual |
0.524 |
structured |
562 |
name=James L. Barksdale | current_co=- | edges=- |
730 |
|
| merged |
716 |
individual |
0.389 |
structured |
419 |
name=Robert Nelsen | current_co=ARCH Venture Partners | edges=employed_at->ARCH Venture Partners; founded->ARCH Venture Partners |
900 |
|
| pending |
7582 |
company |
0.636 |
trigram_core |
1016 |
name=CX2 Technologies | type=unknown roles={company} | sector=Defense / Aerospace | hq=Arlington/US | domains=cx2.com | edges=2 | src_text=- |
4676 |
|
| pending |
7583 |
company |
0.65 |
trigram_core |
1016 |
name=CX2 Technologies | type=unknown roles={company} | sector=Defense / Aerospace | hq=Arlington/US | domains=cx2.com | edges=2 | src_text=- |
4677 |
|
| pending |
7584 |
company |
0.609 |
trigram_core |
1142 |
name=Mersive Technologies | type=company roles={company} | sector=Enterprise SaaS | hq=Denver/US | domains=mersive.com | edges=1 | src_te... |
4677 |
|
| pending |
7585 |
company |
0.667 |
trigram_core |
1145 |
name=CA Technologies | type=company roles={company} | sector=Enterprise SaaS | hq=New York/US | domains=ca.com | edges=2 | src_text=- |
4676 |
|
| pending |
7586 |
company |
0.684 |
trigram_core |
1145 |
name=CA Technologies | type=company roles={company} | sector=Enterprise SaaS | hq=New York/US | domains=ca.com | edges=2 | src_text=- |
4677 |
|
| pending |
7598 |
company |
0.619 |
trigram_core |
2418 |
name=Rune Technologies | type=company roles={company} | sector=Defense Logistics Software | hq=San Francisco/US | domains=- | edges=5 | s... |
4677 |
|
| pending |
13193 |
company |
0.6 |
trigram_core |
1653 |
name=Velocity | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=14 | src_text=[subscription] Velocity, a one-year-old Lon... |
5303 |
|
| pending |
13219 |
company |
0.632 |
trigram_core |
3651 |
name=Lo Biosciences, Inc. | type=company roles={} | sector=- | hq=-/US | domains=- | edges=0 | src_text=- |
5314 |
|
| pending |
17679 |
company |
0.636 |
trigram_core |
4678 |
name=Up Therapeutics, Inc. | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=4 | src_text=- |
6122 |
|
| pending |
21515 |
company |
0.619 |
trigram_core |
5004 |
name=Tune Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
6498 |
|
| pending |
21523 |
company |
0.636 |
trigram_core |
5232 |
name=Sharp Therapeutics | type=company roles={} | sector=Drug Discovery | hq=-/US | domains=sharptx.com | edges=1 | src_text=- |
6498 |
|
| pending |
21527 |
company |
0.6 |
trigram_core |
5314 |
name=IMU Biosciences | type=company roles={} | sector=Life Sciences | hq=-/US | domains=- | edges=1 | src_text=- |
6493 |
|
| pending |
21537 |
company |
0.609 |
trigram_core |
5792 |
name=Siamab Therapeutics | type=company roles={} | sector=Biotechnology | hq=-/US | domains=- | edges=1 | src_text=- |
6498 |
|
| pending |
21543 |
company |
0.65 |
trigram_core |
6067 |
name=MG Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
6498 |
|
| pending |
21544 |
company |
0.7 |
trigram_core |
6093 |
name=S1P Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
6498 |
|
| pending |
41361 |
company |
0.619 |
trigram_core |
324 |
name=Trevi Therapeutics | type=company roles={company} | sector=Biotech & Drug Discovery | hq=-/US | domains=trevitherapeutics.com | edge... |
7045 |
|
| pending |
41369 |
company |
0.667 |
trigram_core |
622 |
name=Science Inc. | type=firm roles={firm} | sector=- | hq=Los Angeles/US | domains=scienceinc.com | edges=2 | src_text=[subscription] Sc... |
7055 |
|
| pending |
41400 |
company |
0.647 |
trigram_core |
1135 |
name=Technology Management Associates | type=unknown roles={company} | sector=Defense / Aerospace | hq=Herndon/US | domains=- | edges=10 ... |
7053 |
|
| pending |
41449 |
company |
0.65 |
trigram_core |
2296 |
name=Ona Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=Ona Therapeuti... |
7045 |
|
| pending |
41450 |
company |
0.619 |
trigram_core |
2296 |
name=Ona Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=Ona Therapeuti... |
7057 |
|
| pending |
41461 |
company |
0.619 |
trigram_core |
3314 |
name=Rise Therapeutics, LLC | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7045 |
|
| pending |
41462 |
company |
0.636 |
trigram_core |
3556 |
name=Cometa Therapeutics Inc | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7045 |
|
| pending |
41468 |
company |
0.65 |
trigram_core |
3651 |
name=Lo Biosciences, Inc. | type=company roles={} | sector=- | hq=-/US | domains=- | edges=0 | src_text=- |
7049 |
|
| pending |
41475 |
company |
0.625 |
trigram_core |
4573 |
name=Glycot Therapeutics, LLC | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7046 |
|
| pending |
41495 |
company |
0.684 |
trigram_core |
4678 |
name=Up Therapeutics, Inc. | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=4 | src_text=- |
7045 |
|
| pending |
41496 |
company |
0.619 |
trigram_core |
4678 |
name=Up Therapeutics, Inc. | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=4 | src_text=- |
7048 |
|
| pending |
41497 |
company |
0.619 |
trigram_core |
4678 |
name=Up Therapeutics, Inc. | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=4 | src_text=- |
7050 |
|
| pending |
41498 |
company |
0.65 |
trigram_core |
4678 |
name=Up Therapeutics, Inc. | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=4 | src_text=- |
7057 |
|
| pending |
41511 |
company |
0.609 |
trigram_core |
4940 |
name=Aer Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
7043 |
|
| pending |
41512 |
company |
0.65 |
trigram_core |
4940 |
name=Aer Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
7045 |
|
| pending |
41513 |
company |
0.619 |
trigram_core |
4940 |
name=Aer Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
7057 |
|
| pending |
41522 |
company |
0.609 |
trigram_core |
4942 |
name=AN2 Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
7043 |
|
| pending |
41523 |
company |
0.65 |
trigram_core |
4942 |
name=AN2 Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
7045 |
|
| pending |
41524 |
company |
0.619 |
trigram_core |
4942 |
name=AN2 Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
7057 |
|
| pending |
41529 |
company |
0.625 |
trigram_core |
4998 |
name=Spolia Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
7056 |
|
| merged |
811 |
individual |
0.55 |
structured |
564 |
name=Howard Cox | current_co=- | edges=- |
878 |
|
| rejected |
801 |
individual |
0.5 |
structured |
612 |
name=Craig Maurice Epps | current_co=- | edges=colleague->?; educated_at->Rutgers University |
795 |
|
| rejected |
468 |
company |
0.643 |
trigram_core |
23 |
name=Headline | type=firm roles={firm} | sector=- | hq=-/US | domains=headline.com | edges=2 | src_text=- |
1937 |
|
| rejected |
474 |
company |
0.615 |
trigram_core |
124 |
name=Samsung Next | type=firm roles={firm} | sector=- | hq=San Francisco/US | domains=- | edges=0 | src_text=- |
493 |
|
| rejected |
473 |
company |
0.647 |
trigram_core |
110 |
name=Conviction Embed | type=firm roles={firm} | sector=- | hq=San Francisco/US | domains=- | edges=0 | src_text=- |
585 |
|
| pending |
8587 |
company |
0.619 |
trigram_core |
324 |
name=Trevi Therapeutics | type=company roles={company} | sector=Biotech & Drug Discovery | hq=-/US | domains=trevitherapeutics.com | edge... |
4678 |
|
| pending |
8591 |
company |
0.615 |
trigram_core |
622 |
name=Science Inc. | type=firm roles={firm} | sector=- | hq=Los Angeles/US | domains=scienceinc.com | edges=2 | src_text=[subscription] Sc... |
4679 |
|
| pending |
8600 |
company |
0.619 |
trigram_core |
1016 |
name=CX2 Technologies | type=unknown roles={company} | sector=Defense / Aerospace | hq=Arlington/US | domains=cx2.com | edges=2 | src_text=- |
4680 |
|
| pending |
8604 |
company |
0.65 |
trigram_core |
1145 |
name=CA Technologies | type=company roles={company} | sector=Enterprise SaaS | hq=New York/US | domains=ca.com | edges=2 | src_text=- |
4680 |
|
| pending |
8616 |
company |
0.65 |
trigram_core |
2296 |
name=Ona Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=Ona Therapeuti... |
4678 |
|
| pending |
8618 |
company |
0.619 |
trigram_core |
3314 |
name=Rise Therapeutics, LLC | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
4678 |
|
| pending |
8619 |
company |
0.65 |
trigram_core |
4677 |
name=MS Technologies Corporation | type=? roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
4680 |
|
| pending |
13491 |
company |
0.667 |
trigram_core |
146 |
name=FORWARD.one | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=3 | src_text=- |
5411 |
|
| pending |
13502 |
company |
0.769 |
trigram_core |
355 |
name=Construct Capital | type=firm roles={firm} | sector=- | hq=Washington/US | domains=construct.vc | edges=2 | src_text=- |
5367 |
|
| pending |
13508 |
company |
0.75 |
trigram_core |
710 |
name=Rally Ventures | type=firm roles={firm} | sector=- | hq=Minneapolis/US | domains=rallyventures.com | edges=1 | src_text=- |
5397 |
|
| pending |
13523 |
company |
0.692 |
trigram_core |
1527 |
name=Synthetic | type=company roles={company} | sector=Enterprise SaaS | hq=San Francisco/USA | domains=- | edges=0 | src_text=- |
5361 |
|
| pending |
13525 |
company |
0.727 |
trigram_core |
1665 |
name=Cadenza VC | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
5437 |
|
| rejected |
17720 |
individual |
0.98 |
operator (preemptive) |
480 |
name=Troy Maurice Pearsall | current_co=Parallex LLC | edges=advisor->?; advisor->Product Lab LLC; board_member->Cirrus Seven; board_memb... |
699 |
|
| pending |
21584 |
company |
0.69 |
trigram_core |
951 |
name=University of Virginia | type=university roles={university} | sector=- | hq=Charlottesville/US | domains=virginia.edu | edges=3 | sr... |
6541 |
|
| pending |
21585 |
company |
0.697 |
trigram_core |
951 |
name=University of Virginia | type=university roles={university} | sector=- | hq=Charlottesville/US | domains=virginia.edu | edges=3 | sr... |
6542 |
|
| pending |
21586 |
company |
0.769 |
trigram_core |
951 |
name=University of Virginia | type=university roles={university} | sector=- | hq=Charlottesville/US | domains=virginia.edu | edges=3 | sr... |
6543 |
|
| pending |
21587 |
company |
0.625 |
trigram_core |
951 |
name=University of Virginia | type=university roles={university} | sector=- | hq=Charlottesville/US | domains=virginia.edu | edges=3 | sr... |
6583 |
|
| pending |
21588 |
company |
0.625 |
trigram_core |
963 |
name=Columbia University | type=university roles={university} | sector=- | hq=New York/US | domains=columbia.edu | edges=3 | src_text=- |
6627 |
|
| pending |
21589 |
company |
0.771 |
trigram_core |
964 |
name=University of Pennsylvania | type=university roles={university} | sector=- | hq=Philadelphia/US | domains=- | edges=3 | src_text=- |
6557 |
|
| pending |
21595 |
company |
0.622 |
trigram_core |
1048 |
name=University of Maryland | type=university roles={university} | sector=- | hq=College Park/US | domains=umd.edu | edges=3 | src_text=- |
6581 |
|
| pending |
21615 |
company |
0.667 |
trigram_core |
1181 |
name=Florida A&M University | type=university roles={university} | sector=HBCU 1890 land-grant research university — agriculture (College... |
6561 |
|
| pending |
21726 |
company |
0.667 |
trigram_core |
5354 |
name=North Carolina State University | type=university roles={} | sector=- | hq=-/US | domains=- | edges=0 | src_text=- |
6545 |
|
| pending |
21727 |
company |
0.75 |
trigram_core |
5354 |
name=North Carolina State University | type=university roles={} | sector=- | hq=-/US | domains=- | edges=0 | src_text=- |
6615 |
|
| pending |
21746 |
company |
0.633 |
trigram_core |
6397 |
name=University of Florida | type=university roles={} | sector=- | hq=Gainesville/US | domains=- | edges=4 | src_text=- |
6561 |
|
| pending |
21747 |
company |
0.613 |
trigram_core |
6539 |
name=Lincoln University | type=university roles={} | sector=- | hq=Lincoln University/US | domains=- | edges=0 | src_text=- |
6599 |
|
| pending |
21748 |
company |
0.633 |
trigram_core |
6540 |
name=Alabama State University | type=university roles={} | sector=- | hq=Montgomery/US | domains=- | edges=0 | src_text=- |
6547 |
|
| pending |
21749 |
company |
0.679 |
trigram_core |
6540 |
name=Alabama State University | type=university roles={} | sector=- | hq=Montgomery/US | domains=- | edges=0 | src_text=- |
6569 |
|
| pending |
21750 |
company |
0.633 |
trigram_core |
6540 |
name=Alabama State University | type=university roles={} | sector=- | hq=Montgomery/US | domains=- | edges=0 | src_text=- |
6603 |
|
| pending |
21751 |
company |
0.69 |
trigram_core |
6541 |
name=Virginia State University | type=university roles={} | sector=- | hq=Petersburg/US | domains=- | edges=0 | src_text=- |
6543 |
|
| pending |
21752 |
company |
0.839 |
trigram_core |
6541 |
name=Virginia State University | type=university roles={} | sector=- | hq=Petersburg/US | domains=- | edges=0 | src_text=- |
6597 |
|
| pending |
21753 |
company |
0.655 |
trigram_core |
6547 |
name=Albany State University | type=university roles={} | sector=- | hq=Albany/US | domains=- | edges=0 | src_text=- |
6603 |
|
| pending |
21754 |
company |
0.611 |
trigram_core |
6577 |
name=Lawson State Community College | type=university roles={} | sector=- | hq=Birmingham/US | domains=- | edges=0 | src_text=- |
6591 |
|
| pending |
21755 |
company |
0.615 |
trigram_core |
6590 |
name=Mississippi Valley State University | type=university roles={} | sector=- | hq=Itta Bena/US | domains=- | edges=0 | src_text=- |
6593 |
|
| pending |
21756 |
company |
0.714 |
trigram_core |
6601 |
name=Morris Brown College | type=university roles={} | sector=- | hq=Atlanta/US | domains=- | edges=0 | src_text=- |
6610 |
|
| pending |
41532 |
company |
0.619 |
trigram_core |
5002 |
name=Ten63 Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
7045 |
|
| pending |
41537 |
company |
0.65 |
trigram_core |
5004 |
name=Tune Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
7045 |
|
| pending |
41538 |
company |
0.619 |
trigram_core |
5004 |
name=Tune Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
7057 |
|
| pending |
41539 |
company |
0.682 |
trigram_core |
5004 |
name=Tune Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
7058 |
|
| pending |
41543 |
company |
0.652 |
trigram_core |
5033 |
name=Arin Technologies | type=company roles={} | sector=Electronics | hq=-/US | domains=- | edges=1 | src_text=- |
7051 |
|
| pending |
41546 |
company |
0.609 |
trigram_core |
5169 |
name=Myris Therapeutics | type=company roles={} | sector=Biotechnology | hq=-/US | domains=- | edges=1 | src_text=- |
7050 |
|
| pending |
41549 |
company |
0.615 |
trigram_core |
5263 |
name=Thar Pharmaceuticals, Inc. | type=company roles={} | sector=Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
7047 |
|
| pending |
41550 |
company |
0.615 |
trigram_core |
5263 |
name=Thar Pharmaceuticals, Inc. | type=company roles={} | sector=Drug Discovery | hq=-/US | domains=- | edges=1 | src_text=- |
7052 |
|
| pending |
41569 |
company |
0.684 |
trigram_core |
6067 |
name=MG Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7045 |
|
| pending |
41570 |
company |
0.619 |
trigram_core |
6067 |
name=MG Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7048 |
|
| pending |
41571 |
company |
0.7 |
trigram_core |
6067 |
name=MG Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7050 |
|
| rejected |
509 |
company |
0.692 |
trigram_core |
799 |
name=Stanford Management Company | type=university roles={university} | sector=- | hq=Stanford/US | domains=smc.stanford.edu | edges=2 | ... |
924 |
|
| rejected |
510 |
company |
0.618 |
trigram_core |
805 |
name=PRINCO (Princeton University Investment Company) | type=university roles={university} | sector=- | hq=Princeton/US | domains=princo.... |
901 |
|
| rejected |
512 |
company |
0.605 |
trigram_core |
903 |
name=University of Southern California | type=university roles={university} | sector=- | hq=Los Angeles/US | domains=usc.edu | edges=0 | ... |
914 |
|
| rejected |
513 |
company |
0.609 |
trigram_core |
905 |
name=Harvard University | type=university roles={university} | sector=- | hq=Cambridge/US | domains=harvard.edu | edges=2 | src_text=- |
1177 |
|
| rejected |
514 |
company |
0.622 |
trigram_core |
913 |
name=University of Michigan | type=university roles={university} | sector=- | hq=Ann Arbor/US | domains=umich.edu | edges=2 | src_text=- |
934 |
|
| rejected |
469 |
company |
0.6 |
trigram_core |
37 |
name=Founders Future | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
140 |
|
| rejected |
470 |
company |
0.611 |
trigram_core |
53 |
name=Minish Technology | type=? roles={company} | sector=- | hq=-/US | domains=- | edges=0 | src_text=- |
1135 |
|
| rejected |
475 |
company |
0.615 |
trigram_core |
124 |
name=Samsung Next | type=firm roles={firm} | sector=- | hq=San Francisco/US | domains=- | edges=0 | src_text=- |
1969 |
|
| rejected |
477 |
company |
0.6 |
trigram_core |
140 |
name=Founders Fund | type=firm roles={firm} | sector=- | hq=San Francisco/US | domains=foundersfund.com | edges=30 | src_text=- |
1344 |
|
| rejected |
479 |
company |
0.611 |
trigram_core |
161 |
name=WTT Investment | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=0 | src_text=- |
1884 |
|
| rejected |
480 |
company |
0.611 |
trigram_core |
161 |
name=WTT Investment | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=0 | src_text=- |
1953 |
|
| rejected |
482 |
company |
0.6 |
trigram_core |
172 |
name=RTW Investments | type=firm roles={firm} | sector=- | hq=New York/US | domains=- | edges=0 | src_text=- |
2131 |
|
| rejected |
484 |
company |
0.6 |
trigram_core |
211 |
name=ExM Investment Partners | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=0 | src_text=- |
801 |
|
| rejected |
485 |
company |
0.611 |
trigram_core |
211 |
name=ExM Investment Partners | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=0 | src_text=- |
1884 |
|
| rejected |
486 |
company |
0.611 |
trigram_core |
211 |
name=ExM Investment Partners | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=0 | src_text=- |
1953 |
|
| rejected |
490 |
company |
0.615 |
trigram_core |
339 |
name=HCI Equity Partners | type=firm roles={firm} | sector=- | hq=Washington/US | domains=hciequity.com | edges=1 | src_text=- |
2185 |
|
| rejected |
497 |
company |
0.667 |
trigram_core |
582 |
name=Andreessen Horowitz Growth | type=firm roles={firm} | sector=- | hq=Menlo Park/US | domains=- | edges=0 | src_text=[alert] Andreesse... |
593 |
|
| rejected |
502 |
company |
1.0 |
name_core+trigram_core |
650 |
name=Capital Factory | type=firm roles={firm} | sector=- | hq=Austin/US | domains=capitalfactory.com | edges=2 | src_text=- |
2095 |
|
| rejected |
505 |
company |
0.636 |
trigram_core |
758 |
name=Origin Ventures | type=firm roles={firm} | sector=- | hq=Chicago/US | domains=originventures.com | edges=2 | src_text=- |
1478 |
|
| rejected |
511 |
company |
1.0 |
name_core+trigram_core |
879 |
name=Mercury Fund | type=firm roles={firm} | sector=- | hq=Houston/US | domains=mercuryfund.com | edges=1 | src_text=- |
1726 |
|
| pending |
8663 |
company |
0.636 |
trigram_core |
2296 |
name=Ona Therapeutics | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=Ona Therapeuti... |
4681 |
|
| pending |
13946 |
company |
0.643 |
trigram_core |
1103 |
name=Emigrant Bank | type=unknown roles={company} | sector=- | hq=New York/US | domains=emigrantbank.com | edges=3 | src_text=- |
5454 |
|
| merged |
18293 |
company |
1.0 |
same_entity |
1538 |
name=Inxight Software | type=company roles={company} | sector=Enterprise SaaS | hq=-/US | domains=- | edges=5 | src_text=- |
2102 |
|
| pending |
22017 |
company |
1.0 |
name_core+trigram_core |
1044 |
name=TASC Inc | type=company roles={company} | sector=Defense / Aerospace | hq=Chantilly/US | domains=- | edges=3 | src_text=- |
6649 |
|
| pending |
41572 |
company |
0.65 |
trigram_core |
6067 |
name=MG Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7057 |
|
| pending |
41573 |
company |
0.65 |
trigram_core |
6093 |
name=S1P Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7045 |
|
| pending |
41574 |
company |
0.636 |
trigram_core |
6093 |
name=S1P Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7056 |
|
| pending |
41575 |
company |
0.619 |
trigram_core |
6093 |
name=S1P Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7057 |
|
| pending |
41577 |
company |
0.619 |
trigram_core |
6108 |
name=Overa Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7045 |
|
| pending |
41578 |
company |
0.625 |
trigram_core |
6219 |
name=PreAct Technologies | type=company roles={} | sector=Software-definable flash LiDAR sensors | hq=Portland/US | domains=- | edges=0 |... |
7054 |
|
| pending |
41580 |
company |
0.632 |
trigram_core |
6267 |
name=P3 Technology | type=company roles={} | sector=AI surfacing insights from people with disabilities | hq=New Orleans/US | domains=- |... |
7053 |
|
| pending |
41583 |
company |
0.65 |
trigram_core |
6498 |
name=SPR Therapeutics | type=company roles={} | sector=Neurostimulation (SPRINT peripheral nerve stim) | hq=Cleveland/US | domains=- | ed... |
7045 |
|
| pending |
41584 |
company |
0.714 |
trigram_core |
6498 |
name=SPR Therapeutics | type=company roles={} | sector=Neurostimulation (SPRINT peripheral nerve stim) | hq=Cleveland/US | domains=- | ed... |
7056 |
|
| pending |
41585 |
company |
0.619 |
trigram_core |
6498 |
name=SPR Therapeutics | type=company roles={} | sector=Neurostimulation (SPRINT peripheral nerve stim) | hq=Cleveland/US | domains=- | ed... |
7057 |
|
| pending |
41596 |
company |
0.63 |
trigram_core |
6665 |
name=CytoImmune Therapeutics | type=company roles={} | sector=Life Sciences | hq=Toa Baja/US | domains=- | edges=0 | src_text=- |
7058 |
|
| pending |
41597 |
company |
0.684 |
trigram_core |
6691 |
name=G1 Therapeutics | type=company roles={} | sector=Life Sciences | hq=Research Triangle Park/US | domains=- | edges=0 | src_text=- |
7045 |
|
| merged |
11207 |
company |
1.0 |
same_entity |
3 |
name=Meta | type=company roles={company} | sector=AI Application | hq=-/US | domains=meta.com | edges=23 | src_text=[subscription] Meta —... |
1377 |
|
| pending |
14041 |
company |
0.6 |
trigram_core |
1444 |
name=Photonic | type=company roles={company} | sector=AI Infrastructure | hq=Vancouver/Canada | domains=- | edges=0 | src_text=- |
5547 |
|
| pending |
14043 |
company |
0.625 |
trigram_core |
1616 |
name=Arche Capital | type=firm roles={firm/investor} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
5553 |
|
| pending |
14045 |
company |
0.75 |
trigram_core |
1657 |
name=Distribution Ventures | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
5674 |
|
| pending |
14091 |
company |
0.615 |
trigram_core |
5470 |
name=Cleanhaus | type=company roles={} | sector=Consumer Products | hq=-/US | domains=- | edges=1 | src_text=- |
5621 |
|
| pending |
14092 |
company |
0.667 |
trigram_core |
5480 |
name=Madora | type=company roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
5570 |
|
| pending |
14093 |
company |
0.667 |
trigram_core |
5590 |
name=TextRebates | type=company roles={} | sector=B2B Software | hq=-/US | domains=- | edges=1 | src_text=- |
5645 |
|
| pending |
14094 |
company |
0.727 |
trigram_core |
5598 |
name=Trova Trip | type=company roles={} | sector=Consumer Products | hq=-/US | domains=- | edges=1 | src_text=- |
5694 |
|
| pending |
18333 |
company |
0.647 |
trigram_core |
1135 |
name=Technology Management Associates | type=unknown roles={company} | sector=Defense / Aerospace | hq=Herndon/US | domains=- | edges=10 ... |
6132 |
|
| pending |
29299 |
company |
1.0 |
name_core+trigram_core |
3674 |
name=Cartesian Therapeutics, Inc. | type=company roles={} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
6659 |
|
| pending |
41598 |
company |
0.667 |
trigram_core |
6691 |
name=G1 Therapeutics | type=company roles={} | sector=Life Sciences | hq=Research Triangle Park/US | domains=- | edges=0 | src_text=- |
7046 |
|
| pending |
41599 |
company |
0.619 |
trigram_core |
6691 |
name=G1 Therapeutics | type=company roles={} | sector=Life Sciences | hq=Research Triangle Park/US | domains=- | edges=0 | src_text=- |
7048 |
|
| pending |
41600 |
company |
0.619 |
trigram_core |
6691 |
name=G1 Therapeutics | type=company roles={} | sector=Life Sciences | hq=Research Triangle Park/US | domains=- | edges=0 | src_text=- |
7050 |
|
| pending |
41601 |
company |
0.65 |
trigram_core |
6691 |
name=G1 Therapeutics | type=company roles={} | sector=Life Sciences | hq=Research Triangle Park/US | domains=- | edges=0 | src_text=- |
7057 |
|
| pending |
41603 |
company |
0.647 |
trigram_core |
6851 |
name=Ne Scientific, Inc. | type=company roles={} | sector=- | hq=-/US | domains=- | edges=3 | src_text=- |
7044 |
|
| pending |
41604 |
company |
0.632 |
trigram_core |
6946 |
name=Clear Scientific, LLC | type=company roles={} | sector=- | hq=-/US | domains=- | edges=5 | src_text=- |
7044 |
|
| pending |
41605 |
company |
0.609 |
trigram_core |
6984 |
name=Cerevel Therapeutics, LLC | type=company roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
7045 |
|
| pending |
41606 |
company |
0.619 |
trigram_core |
7045 |
name=CX Therapeutics, Inc | type=company roles={} | sector=- | hq=-/US | domains=- | edges=2 | src_text=- |
7048 |
|
| pending |
41607 |
company |
0.619 |
trigram_core |
7045 |
name=CX Therapeutics, Inc | type=company roles={} | sector=- | hq=-/US | domains=- | edges=2 | src_text=- |
7050 |
|
| pending |
41608 |
company |
0.65 |
trigram_core |
7045 |
name=CX Therapeutics, Inc | type=company roles={} | sector=- | hq=-/US | domains=- | edges=2 | src_text=- |
7057 |
|
| pending |
41881 |
company |
0.619 |
trigram_core |
6067 |
name=MG Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7750 |
|
| pending |
41882 |
company |
0.619 |
trigram_core |
6067 |
name=MG Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7754 |
|
| pending |
41883 |
company |
0.619 |
trigram_core |
6067 |
name=MG Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7760 |
|
| pending |
41884 |
company |
0.619 |
trigram_core |
6067 |
name=MG Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7782 |
|
| pending |
41888 |
company |
0.609 |
trigram_core |
6093 |
name=S1P Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7753 |
|
| pending |
41891 |
company |
0.636 |
trigram_core |
6108 |
name=Overa Therapeutics | type=company roles={firm} | sector=Biotech & Drug Discovery | hq=-/US | domains=- | edges=0 | src_text=- |
7750 |
|
| pending |
41895 |
company |
0.625 |
trigram_core |
6275 |
name=NOMAD | type=company roles={} | sector=AI-powered screen-free hiking system | hq=Houston/US | domains=- | edges=0 | src_text=- |
7771 |
|
| pending |
41901 |
company |
0.609 |
trigram_core |
6498 |
name=SPR Therapeutics | type=company roles={} | sector=Neurostimulation (SPRINT peripheral nerve stim) | hq=Cleveland/US | domains=- | ed... |
7753 |
|
| pending |
41918 |
company |
0.619 |
trigram_core |
6691 |
name=G1 Therapeutics | type=company roles={} | sector=Life Sciences | hq=Research Triangle Park/US | domains=- | edges=0 | src_text=- |
7750 |
|
| pending |
41919 |
company |
0.619 |
trigram_core |
6691 |
name=G1 Therapeutics | type=company roles={} | sector=Life Sciences | hq=Research Triangle Park/US | domains=- | edges=0 | src_text=- |
7754 |
|
| pending |
41920 |
company |
0.619 |
trigram_core |
6691 |
name=G1 Therapeutics | type=company roles={} | sector=Life Sciences | hq=Research Triangle Park/US | domains=- | edges=0 | src_text=- |
7760 |
|
| pending |
41921 |
company |
0.619 |
trigram_core |
6691 |
name=G1 Therapeutics | type=company roles={} | sector=Life Sciences | hq=Research Triangle Park/US | domains=- | edges=0 | src_text=- |
7782 |
|
| pending |
41922 |
company |
0.714 |
trigram_core |
6692 |
name=Well | type=company roles={} | sector=Health-Tech | hq=Chapel Hill/US | domains=- | edges=0 | src_text=- |
7781 |
|
| pending |
41925 |
company |
0.65 |
trigram_core |
6898 |
name=Bloomer Health Tech Inc | type=company roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
7766 |
|
| pending |
41927 |
company |
0.679 |
trigram_core |
6976 |
name=Immunochem Therapeutics, LLC | type=company roles={} | sector=- | hq=-/US | domains=- | edges=3 | src_text=- |
7747 |
|
| pending |
41932 |
company |
0.7 |
trigram_core |
7045 |
name=CX Therapeutics, Inc | type=company roles={} | sector=- | hq=-/US | domains=- | edges=2 | src_text=- |
7750 |
|
| pending |
41933 |
company |
0.619 |
trigram_core |
7045 |
name=CX Therapeutics, Inc | type=company roles={} | sector=- | hq=-/US | domains=- | edges=2 | src_text=- |
7754 |
|
| pending |
41934 |
company |
0.667 |
trigram_core |
7045 |
name=CX Therapeutics, Inc | type=company roles={} | sector=- | hq=-/US | domains=- | edges=2 | src_text=- |
7755 |
|
| pending |
41935 |
company |
0.619 |
trigram_core |
7045 |
name=CX Therapeutics, Inc | type=company roles={} | sector=- | hq=-/US | domains=- | edges=2 | src_text=- |
7760 |
|
| pending |
41936 |
company |
0.619 |
trigram_core |
7045 |
name=CX Therapeutics, Inc | type=company roles={} | sector=- | hq=-/US | domains=- | edges=2 | src_text=- |
7782 |
|
| pending |
41937 |
company |
0.625 |
trigram_core |
7530 |
name=Mindgrasp.io | type=company roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
7770 |
|
| pending |
41938 |
company |
0.711 |
trigram_core |
7671 |
name=Comprehensive Rehab Services | type=company roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
7751 |
|
| pending |
41939 |
company |
0.706 |
trigram_core |
7708 |
name=Concious Gear | type=? roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
7769 |
|
| pending |
41940 |
company |
0.688 |
trigram_core |
7734 |
name=BobiHealth | type=company roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
7778 |
|
| pending |
41941 |
company |
0.609 |
trigram_core |
7750 |
name=Cove Therapeutics, Inc. | type=company roles={} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
7755 |
|
| pending |
42980 |
company |
1.0 |
name_core+trigram_core |
848 |
name=University of Utah Ventures | type=firm roles={firm} | sector=- | hq=Salt Lake City/US | domains=utah.edu | edges=0 | src_text=- |
7800 |
|
| pending |
43020 |
company |
0.611 |
trigram_core |
1417 |
name=University of South Florida | type=university roles={company} | sector=- | hq=Tampa/US | domains=usf.edu | edges=0 | src_text=- |
7788 |
|
| pending |
43231 |
company |
0.733 |
trigram_core |
6397 |
name=University of Florida | type=university roles={} | sector=- | hq=Gainesville/US | domains=- | edges=4 | src_text=- |
7788 |
|
| pending |
43232 |
company |
0.643 |
trigram_core |
6398 |
name=Oregon State University | type=university roles={} | sector=- | hq=Corvallis/US | domains=- | edges=1 | src_text=- |
7795 |
|
| pending |
43246 |
company |
0.607 |
trigram_core |
6586 |
name=Bowie State University | type=university roles={} | sector=- | hq=Bowie/US | domains=- | edges=0 | src_text=- |
7795 |
|
| pending |
47367 |
company |
0.625 |
trigram_core |
665 |
name=Valor Ventures | type=firm roles={firm} | sector=- | hq=Atlanta/US | domains=valor.vc | edges=1 | src_text=- |
7836 |
|
| pending |
47422 |
company |
0.75 |
trigram_core |
1613 |
name=Compound VC | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=2 | src_text=- |
7837 |
|
| pending |
47432 |
company |
1.0 |
name_core+trigram_core |
1686 |
name=El Dorado Ventures | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=0 | src_text=- |
7916 |
|
| merged |
48437 |
company |
1.0 |
name_core+trigram_core |
1351 |
name=Ofinno | type=unknown roles={company} | sector=DeepTech / Other | hq=Reston/US | domains=- | edges=0 | src_text=- |
1352 |
|
| pending |
49752 |
company |
0.7 |
trigram_core |
586 |
name=LAUNCH Fund | type=firm roles={firm} | sector=- | hq=San Francisco/US | domains=launch.co | edges=2 | src_text=- |
8021 |
|
| pending |
49764 |
company |
1.0 |
name_core+trigram_core |
786 |
name=Elevate Capital | type=firm roles={firm} | sector=Venture Capital | hq=Portland/US | domains=elevate.vc | edges=80 | src_text=- |
7997 |
|
| pending |
49801 |
company |
1.0 |
name_core+trigram_core |
1169 |
name=JumpStart Inc | type=firm roles={firm} | sector=- | hq=Cleveland/US | domains=jumpstartinc.org | edges=0 | src_text=- |
8020 |
|
| pending |
49882 |
company |
0.611 |
trigram_core |
4378 |
name=Pza Innovation LLC | type=? roles={} | sector=- | hq=-/US | domains=- | edges=0 | src_text=- |
7983 |
|
| pending |
49993 |
company |
0.615 |
trigram_core |
5732 |
name=Elevate K-12 | type=company roles={} | sector=EdTech | hq=-/US | domains=- | edges=1 | src_text=- |
7997 |
|
| pending |
132293 |
company |
0.7 |
trigram_core |
1645 |
name=Galaxy Ventures | type=firm roles={firm} | sector=- | hq=-/US | domains=- | edges=1 | src_text=- |
8158 |
|
| pending |
41691 |
company |
0.75 |
trigram_core |
1539 |
name=Tapestry AI | type=company roles={company} | sector=AI Application | hq=-/US | domains=- | edges=1 | src_text=- |
7767 |
|
| pending |
41692 |
company |
0.652 |
trigram_core |
1603 |
name=Violet Therapeutics | type=company roles={company} | sector=Biotech / Pharma | hq=Somerville/US | domains=- | edges=5 | src_text=- |
7760 |
|
| merged |
12571 |
company |
— |
manual_prior_flag |
4910 |
name=Second Nature | type=company roles={} | sector=Healthcare IT | hq=-/US | domains=- | edges=1 | src_text=- |
4937 |
|